People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cardio Diagnostics Inc. | — | Biotechnology | Series A | $13.2M | $94.1M | 2021 |
| Cardio Diagnostics Holdings, Inc. | — | Biotechnology | Pre-Seed | $1.0M | $5.9M | 2024 |
Meeshanthini Dogan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Meeshanthini Dogan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Elisa Luqman | 2 | 3 |
| Robert Philibert | 2 | 2 |
| Warren Hosseinion | 1 | 4 |
| Paul Burton | 1 | 4 |
| Oded Levy | 1 | 4 |
| Warren Hosseinionn | 1 | 3 |
| Warren Michael Hosseinion | 1 | 1 |
| James Intrater | 1 | 1 |
| Stanley Lau | 1 | 1 |
| Elisa Michael Luqman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.